News
Dermatomyositis and polymyositis are two types of immune-mediated muscle disorders that fall under the umbrella of inflammatory myopathies. Dermatomyositis is more likely to develop during childhood.
Dermatomyositis vs. polymyositis Polymyositis is another inflammatory myopathy that causes muscle swelling, tenderness, and weakness. However, unlike dermatomyositis, polymyositis does not cause ...
Dazukibart targets specific molecular pathology of chronic systemic autoimmune disease. ... including dermatomyositis or polymyositis. ...
A patient with a 2-year history of severe dermatomyositis treated with azathioprine and prednisolone now has stage IV G3 ovarian cancer with rapidly ... her inflammatory myositis, ...
Myositis, a chronic inflammatory disease affecting the muscles, can be classified into various subtypes, including dermatomyositis, polymyositis, and inclusion body myositis. The identification of ...
Although statin therapy is cardioprotective in patients with RA, some clinicians are reluctant to prescribe them to patients with DM/PM-HLD and related myopathy, due to concerns about statin ...
Among patients with myositis, younger individuals with dermatomyositis are more likely to experience pain, while those with polymyositis are more likely to receive opioids, according to data ...
Dermatomyositis is a rare inflammatory disease that causes rash and muscle weakness. There's no cure, but treatments can relieve symptoms. Learn more about this condition.
Dermatomyositis is an uncommon systemic autoimmune disorder of unknown pathogenesis. 1,2 The disorder in adults is characterized by chronic inflammation of the skin and muscles leading to rashes ...
CORONA, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune ...
Learn about the causes and symptoms of amyopathic dermatomyositis. This article also looks at treatment options, diagnosis, and more.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results